Younes M, Eberhardt I, Lemoine R
Institute of Toxicology, Medical University of Lübeck, FRG.
J Appl Toxicol. 1989 Apr;9(2):103-8. doi: 10.1002/jat.2550090206.
To study the effect of iron-overload on hepatic lipid peroxidation, two rat models of haemochromatosis were employed: in the first model resembling secondary haemochromatosis, repeated i.p. injections with Fe-dextran led to an accumulation of Fe in Kupffer cells, while in the second model resembling hereditary haemochromatosis, iron was located mainly in periportal hepatocytes after feeding on a diet containing 3.5% Fe-fumarate for 3 weeks. In both models, total hepatic iron content was elevated four- to fivefold over controls. In vivo lipid peroxidation (ethane exhalation) was enhanced only in the second model, indicating that the hepatocytes are the main targets of Fe-induced lipid peroxidation. Low hepatotoxicity was observed in the second model. Additional treatment of the rats with hepatotoxic agents led to different results: with ethanol and bromobenzene, lipid peroxidation was only evident in both models of iron-overload, while paracetamol-induced lipid peroxidation was seen only in Fe-fumarate-fed rats. CCl4-induced lipid peroxidation was strongly enhanced in both models of haemochromatosis. Hepatotoxicity was enhanced by iron overload only in the case of CCl4-treated, Fe-fumarate-fed rats. The activities of phase I and phase II enzymes of xenobiotic metabolism were not markedly altered in livers of iron-overloaded rats. This implies that neither the bioactivation nor the detoxification of the agents studied were affected in experimental haemochromatosis.
为研究铁过载对肝脏脂质过氧化的影响,采用了两种血色素沉着症大鼠模型:在第一种类似继发性血色素沉着症的模型中,腹腔内反复注射葡聚糖铁导致铁在库普弗细胞中蓄积;而在第二种类似遗传性血色素沉着症的模型中,喂食含3.5%富马酸铁的饲料3周后,铁主要位于门周肝细胞中。在这两种模型中,肝脏总铁含量均比对照组升高了4至5倍。仅在第二种模型中,体内脂质过氧化(乙烷呼出量)增强,表明肝细胞是铁诱导脂质过氧化的主要靶点。在第二种模型中观察到较低的肝毒性。用肝毒性药物对大鼠进行额外处理导致了不同的结果:使用乙醇和溴苯时,脂质过氧化仅在两种铁过载模型中明显,而扑热息痛诱导的脂质过氧化仅在喂食富马酸铁的大鼠中出现。在两种血色素沉着症模型中,四氯化碳诱导的脂质过氧化均强烈增强。仅在四氯化碳处理且喂食富马酸铁的大鼠中,铁过载增强了肝毒性。在铁过载大鼠的肝脏中,外源物代谢的I相和II相酶活性没有明显改变。这意味着在实验性血色素沉着症中,所研究药物的生物活化和解毒均未受到影响。